ScottHOkunoMD

Oncology • Rochester, MN

Sarcoma

Professor, Oncology, Mayo Medical School

Join to view full profile

Dr. Okuno is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Okuno's full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-284-2511

Summary

Dr. Scott Okuno is an oncologist in Rochester, MN and is affiliated with multiple hospitals in the area, including Mayo Clinic Hospital - Rochester, Mayo Clinic Health System in Eau Claire and La Crosse WI. He received his medical degree from University of Illinois College of Medicine at Chicago and has been in practice 28 years. He specializes in sarcoma and is experienced in medical oncology and sarcomas. He has more than 140 publications and over 500 citings.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1992 - 1996
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1989 - 1992
University of Illinois College of MedicineClass of 1989

Certifications & Licensure

FL State Medical License 2014 - 2026
ND State Medical License 2012 - 2026
MT State Medical License 2012 - 2026
IL State Medical License 2012 - 2026
MI State Medical License 2012 - 2025
WI State Medical License 1996 - 2025
TX State Medical License 2016 - 2025
SD State Medical License Active through 2025
MN State Medical License 1990 - 2025
IA State Medical License 1996 - 2025
GA State Medical License 2014 - 2025
CT State Medical License 2019 - 2025
CO State Medical License 2014 - 2025
AZ State Medical License 2014 - 2025
KY State Medical License 2012 - 2024
AK State Medical License 2019 - 2024
OK State Medical License 2019 - 2024
KS State Medical License 2014 - 2020
ID State Medical License 2012 - 2020
MO State Medical License 2013 - 2020
NH State Medical License 2012 - 2020
NY State Medical License 2013 - 2019
American Board of Internal Medicine Medical Oncology
Join now to see all

Awards, Honors, & Recognition

Fellow (FACP) American College of Physicians, 2002

Clinical Trials

Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy Start of enrollment: 1998 Oct 01
Completed
Phase 3
Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer Start of enrollment: 1998 Dec 01
Completed
Phase 3
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Start of enrollment: 2001 Feb 01
Completed
Phase 1, Phase 2
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma Start of enrollment: 2001 Jul 01
Completed
Phase 2
BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma Start of enrollment: 2001 Jun 01
Terminated
Phase 2
CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor Start of enrollment: 2004 Jun 01
Completed
Phase 2
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma Start of enrollment: 2006 Feb 23
Completed
Phase 2
Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg Start of enrollment: 2008 Mar 01
Completed
Phase 2
Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery Start of enrollment: 2001 Aug 01
Completed
Phase 2
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma Start of enrollment: 2011 Apr 01
Completed
Phase 2
Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung Start of enrollment: 2013 Apr 01
Terminated
Phase 2
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes Start of enrollment: 2014 Jul 01
Completed
Phase 2
Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma Start of enrollment: 2014 Jun 13
Completed
Phase 2
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2015 Sep 14
Active, not recruiting
Phase 3
Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) Start of enrollment: 2018 Dec 27
Recruiting
Phase 2
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas Start of enrollment: 2018 Jun 04
Active, not recruiting
Phase 1
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Tolerability and Outcomes for Treatment of Older Myxoid Liposarcoma Population.
Reilly A Coombs, Judith Jebastin Thangaiah, Brittany L Siontis, Steven I Robinson, Scott H Okuno
Cancers. 2024-09-23
Unplanned Excision of Synovial Sarcoma: Factors Associated with Recurrence and Survival.
Samuel E Broida, Alexandra M Arguello, Mikaela H Sullivan, Steven I Robinson, Scott H Okuno
Cancers. 2024-09-14
Cardiac Metastasis from Myxoid Liposarcoma Managed Successfully with Chemotherapy and Radiotherapy: Case Report and Review of the Literature.
Georgios M Stergiopoulos, Brittany L Siontis, Ivy A Petersen, Matthew T Houdek, Thanh P Ho
Current Oncology. 2024-09-12

Journal Articles

Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients with Hereditary Cancer Syndrome
Scott Okuno, Luke Mountjoy, Cameron S Thorpe, Edward D Esplin, Robert L Nussbaum, Alan H Bryce, Tanios S Bekaii-Saab, Aleksandar Sekulic, JAMA Oncology

Lectures

Refining Adjuvant Therapy in Soft Tissue Sarcomas and New Treatments in Bone Sarcomas
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

Salarius Pharmaceuticals Adds Two Mayo Clinic Sites to Its Ongoing Phase 1/2 Trial of Seclidemstat as a Treatment for Ewing’s Sarcoma and FET-Rearranged SarcomasAugust 22nd, 2022
Surprise Wedding Shower 1,000 Miles from HomeAugust 8th, 2022
Innovative Treatment Moves Conner Beyond CancerSeptember 23rd, 2019
Join now to see all